Thyroid hormone receptor

From WikiMD's Wellness Encyclopedia

Thyroid Hormone Receptor

The Thyroid Hormone Receptor (THR) is a type of nuclear receptor that is activated by binding thyroid hormones, such as triiodothyronine (T3) and thyroxine (T4). These receptors play a crucial role in regulating metabolism, development, and differentiation of cells within the human body. The thyroid hormone receptors are encoded by two distinct genes, THRA (Thyroid Hormone Receptor Alpha) and THRB (Thyroid Hormone Receptor Beta), which give rise to several receptor isoforms through alternative splicing.

Function[edit | edit source]

The primary function of thyroid hormone receptors is to modulate gene expression in response to thyroid hormone levels. These receptors act as transcription factors that can either activate or repress target gene expression. In the absence of thyroid hormones, THR associates with co-repressor molecules and inhibits transcription. Upon hormone binding, the receptor undergoes a conformational change, releases co-repressors, and recruits co-activator proteins, leading to the activation of gene transcription.

Thyroid hormone receptors are involved in a wide array of physiological processes, including regulation of metabolic rate, heart rate, body temperature, and growth and development. They also play a significant role in the development of the central nervous system and in maintaining metabolic homeostasis.

Structure[edit | edit source]

Thyroid hormone receptors are composed of several domains: the A/B domain or the N-terminal domain, which is involved in transcriptional activation; the C domain or DNA-binding domain (DBD), which has a high affinity for specific DNA sequences known as thyroid hormone response elements (TREs); the D domain or hinge region, which provides flexibility; and the E/F domain or ligand-binding domain (LBD), which binds thyroid hormones.

Isoforms and Genes[edit | edit source]

The THRA and THRB genes produce multiple isoforms of thyroid hormone receptors through alternative splicing. The most well-known isoforms are TRα1, TRβ1, and TRβ2. These isoforms differ in their tissue distribution, hormone affinity, and physiological functions. For instance, TRα1 is widely expressed in various tissues and is involved in heart rate and metabolic regulation, while TRβ1 is predominantly found in the liver, kidney, and thyroid gland, and TRβ2 is primarily expressed in the hypothalamus and pituitary, playing a key role in the feedback regulation of thyroid hormone production.

Clinical Significance[edit | edit source]

Mutations in the THRA and THRB genes can lead to thyroid hormone resistance syndromes, where tissues are less sensitive to thyroid hormones. This can result in a variety of clinical manifestations, including abnormal growth, developmental delays, and metabolic disorders. Additionally, alterations in thyroid hormone receptor function have been implicated in several diseases, such as hyperthyroidism, hypothyroidism, and certain types of cancer.

Research and Therapeutic Applications[edit | edit source]

Research on thyroid hormone receptors has led to the development of thyroid hormone analogs and receptor-specific agonists and antagonists. These compounds have potential therapeutic applications in treating thyroid disorders, obesity, cholesterol management, and heart disease by selectively modulating thyroid hormone receptor activity.

Contributors: Prab R. Tumpati, MD